Going in alone

Etagen is editing genes using oligos alone

Etagen Pharma, Cambridge, Mass.

Etagen Pharma has developed a single-component gene editing system that capitalizes on the cell's error-free repair machinery, and uses no foreign proteins. That means it can be dosed repeatedly for more shots on goal, with a lower chance of causing an immune response than standard techniques.

The technology employs only chemically modified oligomers - dubbed Etamers - encoding wild-type versions of mutated genes,

Read the full 687 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers